Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : IGNE Igene Biotechnology -- Ignore unavailable to you. Want to Upgrade?

To: criggall who wrote (109)	2/12/2000 10:35:00 AM
From: Robert B.	Respond to of 209

I see what you mean about the products being very similar. Are you saying that if CYAN can find a treatment for carpel tunnel syndrome, then maybe IGNE has the technology to do something similar? cyanotech.com igene.com

To: criggall who wrote (109)	2/12/2000 10:36:00 AM
From: IEarnedIt	Read Replies (1) \| Respond to of 209

Well thanks for clearing that up. Now, as far as assimlation is concerned, I still don't see this as being the same product. Two very different digestive systems going here unless I really did sleep through all of my biology classes as my instructor insisted I did. <ggg> (I told him it was an indicator of his instuctional ability--for some reason he didn't appreciate the comment) :-) JD

To: criggall who wrote (109)	3/20/2000 1:05:00 PM
From: IEarnedIt	Read Replies (1) \| Respond to of 209

Has everyone seen this yet?http://www.freeedgar.com/search/ViewFilings.asp?CIK=793160&Directory=793160&Year=00&SECIndex=2&Extension=.tst&PathFlag=0&TextFileSize=8256&SFType=&SDFiled=&DateFiled=3/17/00&SourcePage=FilingsResults&UseFrame=1&OEMSource=&FormType=NTN_10K&CompanyName=IGENE+BIOTECHNOLOGY+INC This note at the end sounds to me like the lawsuit is just about a done deal. <<United States Security and Exchange Commission Washington, D.C. 20549 Re: Igene Biotechnology, Inc. EIN: 52-1230461 To Whom It May Concern: We are the independent auditors for Igene Biotechnology, Inc. We are unable at this point in time to express an opinion on the Company's December 31, 1999 financial statements or review the 10KSB as Igene is awaiting the outcome of significant subsequent events which could impact the financial statement disclosures. Respectfully yours, /s/ Berenson & Company LLP>> Comments? :-) JD